Literature DB >> 24237039

3-Azatetracyclo[5.2.1.1(5,8).0(1,5)]undecane derivatives: from wild-type inhibitors of the M2 ion channel of influenza A virus to derivatives with potent activity against the V27A mutant.

Matias Rey-Carrizo1, Eva Torres, Chunlong Ma, Marta Barniol-Xicota, Jun Wang, Yibing Wu, Lieve Naesens, William F DeGrado, Robert A Lamb, Lawrence H Pinto, Santiago Vázquez.   

Abstract

We have synthesized and characterized a series of compounds containing the 3-azatetracyclo[5.2.1.1(5,8).0(1,5)]undecane scaffold designed as analogues of amantadine, an inhibitor of the M2 proton channel of influenza A virus. Inhibition of the wild-type (WT) M2 channel and the amantadine-resistant A/M2-S31N and A/M2-V27A mutant ion channels were measured in Xenopus oocytes using two-electrode voltage clamp (TEV) assays. Most of the novel compounds inhibited the WT ion channel in the low micromolar range. Of note, several compounds inhibited the A/M2 V27A mutant ion channel, one of them with submicromolar IC50. None of the compounds was found to inhibit the S31N mutant ion channel. The antiviral activity of three novel dual WT and A/M2-V27A channels inhibitors was confirmed by influenza virus yield assays.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24237039      PMCID: PMC3889466          DOI: 10.1021/jm401340p

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  32 in total

1.  Identification of the pore-lining residues of the BM2 ion channel protein of influenza B virus.

Authors:  Chunlong Ma; Cinque S Soto; Yuki Ohigashi; Albert Taylor; Vasilios Bournas; Brett Glawe; Maria K Udo; William F Degrado; Robert A Lamb; Lawrence H Pinto
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

2.  Structural comparison of the wild-type and drug-resistant mutants of the influenza A M2 proton channel by molecular dynamics simulations.

Authors:  Ruo-Xu Gu; Limin Angela Liu; Yong-Hua Wang; Qin Xu; Dong-Qing Wei
Journal:  J Phys Chem B       Date:  2013-05-09       Impact factor: 2.991

3.  Solution NMR structure of the V27A drug resistant mutant of influenza A M2 channel.

Authors:  Rafal M Pielak; James J Chou
Journal:  Biochem Biophys Res Commun       Date:  2010-09-15       Impact factor: 3.575

4.  Exploring the size limit of templates for inhibitors of the M2 ion channel of influenza A virus.

Authors:  María D Duque; Chunlong Ma; Eva Torres; Jun Wang; Lieve Naesens; Jordi Juárez-Jiménez; Pelayo Camps; F Javier Luque; William F DeGrado; Robert A Lamb; Lawrence H Pinto; Santiago Vázquez
Journal:  J Med Chem       Date:  2011-04-05       Impact factor: 7.446

5.  Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus.

Authors:  Victoria Balannik; Jun Wang; Yuki Ohigashi; Xianghong Jing; Emma Magavern; Robert A Lamb; William F Degrado; Lawrence H Pinto
Journal:  Biochemistry       Date:  2009-12-22       Impact factor: 3.162

6.  Maturation of influenza A virus hemagglutinin--estimates of the pH encountered during transport and its regulation by the M2 protein.

Authors:  S Grambas; A J Hay
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

7.  Large-scale sequence analysis of M gene of influenza A viruses from different species: mechanisms for emergence and spread of amantadine resistance.

Authors:  Yuki Furuse; Akira Suzuki; Hitoshi Oshitani
Journal:  Antimicrob Agents Chemother       Date:  2009-08-03       Impact factor: 5.191

Review 8.  Emerging antiviral strategies to interfere with influenza virus entry.

Authors:  Evelien Vanderlinden; Lieve Naesens
Journal:  Med Res Rev       Date:  2013-06-25       Impact factor: 12.944

9.  Role of the viral hemagglutinin in the anti-influenza virus activity of newly synthesized polycyclic amine compounds.

Authors:  Eva Torres; María D Duque; Evelien Vanderlinden; Chunlong Ma; Lawrence H Pinto; Pelayo Camps; Mathy Froeyen; Santiago Vázquez; Lieve Naesens
Journal:  Antiviral Res       Date:  2013-06-22       Impact factor: 5.970

10.  Anti-influenza virus activity and structure-activity relationship of aglycoristocetin derivatives with cyclobutenedione carrying hydrophobic chains.

Authors:  Lieve Naesens; Evelien Vanderlinden; Erzsébet Roth; József Jeko; Graciela Andrei; Robert Snoeck; Christophe Pannecouque; Eszter Illyés; Gyula Batta; Pál Herczegh; Ferenc Sztaricskai
Journal:  Antiviral Res       Date:  2009-02-05       Impact factor: 5.970

View more
  19 in total

1.  An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.

Authors:  Yanmei Hu; Rami Musharrafieh; Chunlong Ma; Jiantao Zhang; Donald F Smee; William F DeGrado; Jun Wang
Journal:  Antiviral Res       Date:  2017-01-10       Impact factor: 5.970

2.  Discovery of Highly Potent Pinanamine-Based Inhibitors against Amantadine- and Oseltamivir-Resistant Influenza A Viruses.

Authors:  Xin Zhao; Runfeng Li; Yang Zhou; Mengjie Xiao; Chunlong Ma; Zhongjin Yang; Shaogao Zeng; Qiuling Du; Chunguang Yang; Haiming Jiang; Yanmei Hu; Kefeng Wang; Chris Ka Pun Mok; Ping Sun; Jianghong Dong; Wei Cui; Jun Wang; Yaoquan Tu; Zifeng Yang; Wenhui Hu
Journal:  J Med Chem       Date:  2018-06-11       Impact factor: 7.446

3.  Slow but Steady Wins the Race: Dissimilarities among New Dual Inhibitors of the Wild-Type and the V27A Mutant M2 Channels of Influenza A Virus.

Authors:  Marta Barniol-Xicota; Sabrina Gazzarrini; Eva Torres; Yanmei Hu; Jun Wang; Lieve Naesens; Anna Moroni; Santiago Vázquez
Journal:  J Med Chem       Date:  2017-04-24       Impact factor: 7.446

4.  Salinomycin Inhibits Influenza Virus Infection by Disrupting Endosomal Acidification and Viral Matrix Protein 2 Function.

Authors:  Yejin Jang; Jin Soo Shin; Yi-Seul Yoon; Yun Young Go; Hye Won Lee; Oh Seung Kwon; Sehee Park; Man-Seong Park; Meehyein Kim
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

5.  Azapropellanes with anti-influenza a virus activity.

Authors:  Eva Torres; Rosana Leiva; Sabrina Gazzarrini; Matías Rey-Carrizo; Marta Frigolé-Vivas; Anna Moroni; Lieve Naesens; Santiago Vázquez
Journal:  ACS Med Chem Lett       Date:  2014-05-02       Impact factor: 4.345

6.  X-ray Crystal Structures of the Influenza M2 Proton Channel Drug-Resistant V27A Mutant Bound to a Spiro-Adamantyl Amine Inhibitor Reveal the Mechanism of Adamantane Resistance.

Authors:  Jessica L Thomaston; Athina Konstantinidi; Lijun Liu; George Lambrinidis; Jingquan Tan; Martin Caffrey; Jun Wang; William F Degrado; Antonios Kolocouris
Journal:  Biochemistry       Date:  2020-01-13       Impact factor: 3.162

7.  Aminoadamantanes with persistent in vitro efficacy against H1N1 (2009) influenza A.

Authors:  Antonios Kolocouris; Christina Tzitzoglaki; F Brent Johnson; Roland Zell; Anna K Wright; Timothy A Cross; Ian Tietjen; David Fedida; David D Busath
Journal:  J Med Chem       Date:  2014-05-15       Impact factor: 7.446

8.  Flipping in the pore: discovery of dual inhibitors that bind in different orientations to the wild-type versus the amantadine-resistant S31N mutant of the influenza A virus M2 proton channel.

Authors:  Yibing Wu; Belgin Canturk; Hyunil Jo; Chunlong Ma; Eleonora Gianti; Michael L Klein; Lawrence H Pinto; Robert A Lamb; Giacomo Fiorin; Jun Wang; William F DeGrado
Journal:  J Am Chem Soc       Date:  2014-12-18       Impact factor: 15.419

9.  Mechanism and Kinetics of Copper Complexes Binding to the Influenza A M2 S31N and S31N/G34E Channels.

Authors:  Kelly L McGuire; Phillip Smit; Daniel H Ess; Jonathan T Hill; Roger G Harrison; David D Busath
Journal:  Biophys J       Date:  2020-11-26       Impact factor: 4.033

10.  Easily accessible polycyclic amines that inhibit the wild-type and amantadine-resistant mutants of the M2 channel of influenza A virus.

Authors:  Matias Rey-Carrizo; Marta Barniol-Xicota; Chunlong Ma; Marta Frigolé-Vivas; Eva Torres; Lieve Naesens; Salomé Llabrés; Jordi Juárez-Jiménez; Francisco J Luque; William F DeGrado; Robert A Lamb; Lawrence H Pinto; Santiago Vázquez
Journal:  J Med Chem       Date:  2014-06-30       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.